https://www.cidem.cu/proyecto-negocio/ 2023-03-31T19:58:21+00:00 https://www.cidem.cu/proyecto-negocio/cidem-501-503-peptidos-antimicrobianos-con-propiedades-antiinflamatorias-y-capaces-de-evadir-barreras-de-resistencia-en-entornos-infecciosos/ 2023-03-29T19:13:03+00:00 https://www.cidem.cu/proyecto-negocio/cidem-255-desarrollo-de-una-combinacion-innovadora-de-farmacos-a-dosis-fija-para-el-tratamiento-del-dolor-mixto-por-cancer/ 2023-03-29T20:23:16+00:00 https://www.cidem.cu/proyecto-negocio/cidem-113-jm-20-nuevo-agente-neuroprotector-multifuncional-para-el-tratamiento-de-la-enfermedad-del-parkinson-ep/ 2023-03-29T20:28:31+00:00 https://www.cidem.cu/proyecto-negocio/cidem-112-jm-20-nuevo-agente-neuroprotector-multifuncional-para-el-tratamiento-de-la-enfermedad-de-alzheimer-ea-y-otros-tipos-de-demencias/ 2023-03-29T20:32:45+00:00 https://www.cidem.cu/en/proyecto-negocio/antimicrobial-peptides-with-anti-inflammatory-properties-and-capable-of-evading-resistance-barriers-in-infectious-environments/ 2023-03-31T19:13:46+00:00 https://www.cidem.cu/en/proyecto-negocio/cidem-255-development-of-an-innovative-fixed-dose-drug-combination-for-the-treatment-of-mixed-cancer-pain/ 2023-03-31T19:44:04+00:00 https://www.cidem.cu/en/proyecto-negocio/cidem-113-jm-20-novel-multifunctional-neuroprotective-agent-for-the-treatment-of-parkinsons-disease-pd/ 2023-03-31T19:49:13+00:00 https://www.cidem.cu/en/proyecto-negocio/name-phd-alejandro-saul-padron-yaquis-position-general-director-e-mail-address-alejandro-padroncidem-cu-phone-numbers-53-7215-2192-53-7881-0818-address-ave-26-no-1605-e-calzada-de-boyero/ 2023-03-31T19:58:21+00:00 https://www.cidem.cu/en/proyecto-negocio/ 2023-03-31T19:58:21+00:00